Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mari Kurihara"'
Autor:
Takaaki Chou, Kazutaka Sunami, Shuichi Midorikawa, Mohamed H. Zaki, Thomas Doerr, Yoshiaki Ogawa, Shinsuke Iida, Hiromi Iwasaki, Mari Kurihara, Kosei Matsue, Kensei Tobinai
Publikováno v:
Cancer Science
This phase 1, open-label, dose-escalation study investigated the tolerated dose (recommended dose), safety, efficacy, and pharmacokinetics of pomalidomide alone or pomalidomide plus low-dose dexamethasone in Japanese patients with refractory or relap
Autor:
Jun Araki, Mari Kurihara
Publikováno v:
Biomacromolecules. 16:379-388
Sterically stabilized chitin nanowhiskers (ChNWs) were prepared by surface grafting monomethoxy poly(ethylene glycol) (mPEG) via reductive amination of primary amino groups on ChNWs and terminal aldehydes on mPEG. The amount of grafted mPEG was deter
Autor:
Mari Kurihara, Yoshio Sakaguchi, Hisaharu Hayashi, Masato Nanjo, Kunio Mochida, Sayaka Nakamura, Kazuhiko Matsudo
Publikováno v:
Organometallics. 25:832-838
Silylborates (Li[PhnMe3-nSiBPh3], n = 1−3) and germylborates (Li[PhnMe3-nGeBPh3], n = 1−3; M[Et3GeBPh3], M = Li, Na, K) were prepared by the reaction of the corresponding silyl- and germylalkali me...
Autor:
Naoki Masaoka, Kaoru Shimada, Kaori Ohtani, Kazuo Satoh, Nobuhisa Nagai, Takeshi Kanaeda, Hideki Sakamoto, Mari Kurihara
Publikováno v:
Gynecologic Oncology. 79:515-518
Background. Primary squamous cell carcinoma of the ovary is uncommon and has a poor prognosis. Because of its rarity, the effective postoperative treatment is unknown. We describe a remarkable response of this tumor to weekly paclitaxel–carboplatin
Publikováno v:
Journal of Japan Society on Water Environment. 18:803-807
Characteristics of water quality, seasonal variation of DOC and total nitrogen (T-N) concentrations, in the floating-leaved plant Trapa stand were studied in western part of Lake Imba-numa, Chiba Prefecture during three years from April 1990 to April
Autor:
Kazutaka Sunami, Kosei Matsue, Mari Kurihara, Hiromi Iwasaki, Thomas Doerr, Kensei Tobonai, Shinsuke Iida, Shuichi Midorikawa, Mohamed H. Zaki, Takaaki Chou, Yoshiaki Ogawa
Publikováno v:
Blood. 124:2107-2107
Background: Patients (pts) with refractory or relapsed and refractory multiple myeloma (RRMM) who have exhausted treatment (Tx) with lenalidomide (LEN) or thalidomide (THAL) and bortezomib (BORT) have shortened overall survival (OS; Kumar, Leukemia,